W. Bryan Hill - Mar 6, 2024 Form 4 Insider Report for ALKAMI TECHNOLOGY, INC. (ALKT)

Signature
/s/ Douglas A. Linebarger, as Attorney-in-Fact for W. Bryan Hill
Stock symbol
ALKT
Transactions as of
Mar 6, 2024
Transactions value $
-$1,058,700
Form type
4
Date filed
3/8/2024, 04:55 PM
Previous filing
Mar 5, 2024
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKT Common Stock Options Exercise $19K +8.13K +1.6% $2.34* 517K Mar 6, 2024 Direct
transaction ALKT Common Stock Sale -$192K -8.13K -1.57% $23.56 509K Mar 6, 2024 Direct F1
transaction ALKT Common Stock Options Exercise $97.8K +41.8K +8.22% $2.34* 550K Mar 7, 2024 Direct
transaction ALKT Common Stock Sale -$984K -41.8K -7.59% $23.55 509K Mar 7, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKT Stock Option (Right to Buy) Options Exercise $0 -8.13K -0.86% $0.00 942K Mar 6, 2024 Common Stock 8.13K $2.34 Direct F3
transaction ALKT Stock Option (Right to Buy) Options Exercise $0 -41.8K -4.44% $0.00 900K Mar 7, 2024 Common Stock 41.8K $2.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $23.50 to $23.72. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $23.50 to $23.70. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The option are fully vested and exercisable.